Answers are grounded in this paper and cite their sources.
LDA scores reveal taxonomic differences in myeloma patients, indicating toxicity variations related to CRS severity.
Supplementary Figure S18 presents LDA scores that indicate differences in taxonomic abundance based on toxicity profiles in multiple myeloma (MM) patients. The figure shows comparisons between patients with and without cytokine release syndrome (CRS), and further differentiates by CRS grade, specifically highlighting those with grade 2 CRS.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: